Department of Otolaryngology, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Clin Otolaryngol. 2011 Apr;36(2):147-53. doi: 10.1111/j.1749-4486.2011.02274.x.
Previous studies have demonstrated a relationship between elevated serum C-reactive protein (CRP) levels and shorter survival in cancer patients. Few studies, however, have investigated the role of serum CRP levels in oral squamous cell carcinoma. The present study was conducted to analyze the relationship between preoperative CRP levels, clinicopathologic factors, and prognosis in oral squamous cell carcinoma patients.
Retrospective clinical study.
University teaching hospital.
Eighteen oral cavity leukoplakia and 59 oral squamous cell carcinoma patients between November 2006 and November 2009 from the Chang Gung Memorial Hospital.
Clinicopathologic parameters, disease-free survival and overall survival were correlated with CRP levels.
Serum CRP levels were measured preoperatively, and all oral cavity cancer patients underwent curative intent radical surgery with or without postoperative adjuvant therapy.
The CRP levels in leukoplakia patients were used to analyze if factors (including diabetes and liver cirrhosis, smoking, alcohol drinking and areca quid chewing) influence CRP levels, and the results demonstrated they were not associated with CRP elevation (> 5.0 mg/L) (P > 0.05). In oral cancer patients, elevated CRP levels were associated with tumor status (P = 0.005), tumor stage (P = 0.054), bone invasion (P = 0.033), lymph node metastasis (P = 0.004) and lymph node extra-capsular spread (P = 0.018). Patients with higher CRP levels showed poorer disease-free survival (log rank test, P < 0.001) and overall survival (log rank test, P = 0.013).
Preoperative serum CRP levels are associated with advanced tumor stage, bone invasion, lymph node metastasis, lymph node extra-capsular spread and patients' survival. CRP is thus potentially a prognostic indicator, but studies with longer follow-up will be needed to confirm its reliability.
先前的研究表明,血清 C 反应蛋白(CRP)水平升高与癌症患者的生存时间缩短有关。然而,很少有研究调查血清 CRP 水平在口腔鳞状细胞癌中的作用。本研究旨在分析术前 CRP 水平与口腔鳞状细胞癌患者的临床病理因素和预后之间的关系。
回顾性临床研究。
大学教学医院。
2006 年 11 月至 2009 年 11 月期间,来自长庚纪念医院的 18 例口腔白斑病和 59 例口腔鳞状细胞癌患者。
临床病理参数、无病生存率和总生存率与 CRP 水平相关。
术前测量血清 CRP 水平,所有口腔癌患者均行根治性手术治疗,辅以或不辅以术后辅助治疗。
以白斑病患者的 CRP 水平分析是否有(包括糖尿病和肝硬化、吸烟、饮酒和咀嚼槟榔)因素影响 CRP 水平,结果表明它们与 CRP 升高(>5.0mg/L)无关(P>0.05)。在口腔癌患者中,CRP 水平升高与肿瘤状态(P=0.005)、肿瘤分期(P=0.054)、骨侵犯(P=0.033)、淋巴结转移(P=0.004)和淋巴结外膜扩散(P=0.018)相关。CRP 水平较高的患者无病生存率(对数秩检验,P<0.001)和总生存率(对数秩检验,P=0.013)较差。
术前血清 CRP 水平与晚期肿瘤分期、骨侵犯、淋巴结转移、淋巴结外膜扩散和患者生存有关。CRP 因此可能是一个预后指标,但需要更长时间的随访研究来证实其可靠性。